St Jude Medical has enrolled the first patient in EnligHTN II trial of its multi-electrode renal denervation technology for treating patients with drug-resistant hypertension. The CE-marked EnligHTN renal denervation system, which ...
Tags: EnligHTN II trial, Medical, drug resistant hypertension
Takeda Pharmaceutical has received FDA approval for three new type 2 diabetes therapies Nesina (alogliptin) and fixed-dose combinations Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCl). Takeda expects to ...
Tags: FDA, diabetes therapies, Pharmaceuticals
Wireless remote monitoring devices will be used by more than 1.8 million people worldwide in four years, representing a six-fold increase in adoption of telehealth technology, according to a new study by InMedica, part of research firm IHS. ...
Health Canada has issued a notice of compliance for Forest Laboratories Canada's hypertension therapy, Bystolic (nebivolol) tablets. The company anticipates making the hypertension medication, that is to be administered once a day, ...
Covidien has introduced a new therapeutic device to treat patients with resistant hypertension. The CE-marked OneShot Renal Denervation system is an over the wire balloon-based irrigated catheter device which is implanted under the skin ...
Tags: Denervation System, Health, Medicine, resistant hypertension
St Jude Medical's multi-electrode renal denervation technology was proven to be safe and effective and showed sustained reduction in office and ambulatory blood pressure measurements, at six months post treatment in patients with ...
ROX Medical has completed the enrollment of the first patient in its CONTROL-HTN trial, designed to demonstrate the safety and efficacy of the minimally invasive catheter procedure in treating resistant hypertension. The controlled, ...
Tags: ROX Medical, CONTROL-HTN trial, minimally invasive catheter procedure
Medtronic has begun its minimally invasive Symplicity renal denervation system's clinical trial in Japan to treat patients who are not responding to different types of anti-hypertensive medications and are at risk of stroke. The ...
Boston Scientific has entered into a definitive agreement to buy all the assets of Vessix Vascular for an upfront payment of $125m. Under the acquisition, Vessix Vascular will be integrated into Boston Scientific's peripheral ...
Sorin Group, a manufacturer of medical technologies for cardiac surgeries, has enrolled first patients in its Dream clinical trial. The European longitudinal, multi-center, non-randomized trial is designed to assess sensitivity and ...
Tags: Sorin Group, SAM, sleep apnea monitoring
ReCor Medical has presented six-month follow-up data of eight patients treated via renal denervation with the company's Paradise system. The CE-marked Paradise system for renal denervation is based on ultrasound, not radiofrequency, ...
Tags: ReCor Medical, renal denervation, resistant hypertension patients
EnteroMedics has reported subgroup analysis data from EMPOWER trial of its pacemaker-like device, designed to target the multiple digestive functions under control of the vagus nerves and to affect the perception of hunger and fullness. ...
Tags: EnteroMedics, VBLOC, Maestro system
GeNO has obtained a clearance for its inhaled nitric oxide (NO) delivery system, GeNOsyl MV-1000, from the US Food and Drug Administration (FDA). GeNOsyl MV-1000 system, which incorporates a primary delivery system, a backup system, ...
Tags: FDA, inhaled nitric oxide delivery system, clinical product, GeNO
GeNO has received four additional US patents for its proprietary nitric oxide (NO) generation chemistry and delivery technology. The patent No. 8,211,368 describes the conversion of nitrogen dioxide (NO2) to NO where NO2 is stored as ...
Tags: US patent, clinical technology, clinical research, GeNO
Kona Medical has raised additional $10m in equity and debt financing round to bring its total proceeds to $40m. The funding round, in addition to its prior investors Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western ...
Tags: Kona Medical, Series C financing, ultrasound